Intensification of Diabetes Therapy (Erin)

Endocrinology
Curriculum:
Diabetes: Setting Goals and Initiating Therapy
Credits:
0.5 ANCC Contact Hours 0.5 AMA PRA Category 1 Credit(s)™
Launch Date:
June 11, 2014
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Family practitioners, primary care physicians, endocrinologists, nurse practitioners, physician's assistants, and nurses with an interest in diabetes.

Relevant Terms:

Diabetes

Lawrence Blonde, MD

Lawrence Blonde, MD
Director, Diabetes Clinical Research Unit
Internal Medicine Residency Program Director
Ochsner Health System
New Orleans, LA

Lawrence Blonde, MD, FACP, FACE, is director of the Ochsner Diabetes Clinical Research Unit in the Department of Endocrinology, Diabetes and Metabolism at the Ochsner Medical Center in New Orleans, Louisiana.
 
Dr. Blonde’s clinical and research activities have focused on patients with diabetes mellitus and investigations of new therapies and healthcare delivery systems for them. Dr. Blonde is presently an Associate Editor for the journal Diabetes Care. In 2011 he was a member of the Executive Committee and immediate past Chair of the Steering Committee of the National Diabetes Education Program, a partnership of the National Institutes of Health, the Centers for Disease Control and Prevention, and more than 200 public and private organizations working to "change the way diabetes is treated." He was a co-chair and co-author for the 2011 “American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan.” He is also a co-author of the 2013 AACE Comprehensive Diabetes Management Algorithm.
 
Dr. Blonde has been a member of the Board of Directors of AACE the American Association of Clinical Endocrinologists (AACE) and the Board of Trustees of the American College of Endocrinology (ACE). Dr. Blonde has been chair of the American Diabetes Association (ADA) Doing Better Committee, a former member of the ADA board of directors and former chair of the ADA Professional Practice Committee, which develops practice guidelines for the care of people with diabetes.
1. Utilize practice-based tools to efficiently design and modify treatment strategies, enhance collaboration with patients, and increase adherence to treatment plans
2. Intensify treatment in a patient who is not at goal through combination therapy (incretins, TZD's, etc.) to efficiently attain A1C goals

Erin: Intensification of Therapy
 
*Please note that participation in this activity is available for CME and CNE credits only. MOC credits will not be granted solely for participation in these online activities. MOC credit is only available to those participating in a private program that includes two additional QI components.
 
FACULTY
Lawrence Blonde, MD
Director, Diabetes Clinical Research Unit
Internal Medicine Residency Program Director
Ochsner Health System
New Orleans, LA
 
TARGET AUDIENCE
This PI-CME program is designed to meet the educational needs of primary care physicians, endocrinologists, diabetologists, nurses, pharmacists, and other healthcare practitioners involved in the treatment of patients with type 2 diabetes.
 
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
This CME activity was planned and produced in accordance with the ACCME Essentials.
 
CREDIT DESIGNATION STATEMENT
Med Learning Group will designate a maximum of 0.5 AMA PRA Category 1 Credits™ for this case study.
 
Physicians should only claim credit commensurate with the extent of their participation in the activity.
 
NURSING CREDIT INFORMATION
Purpose:
This program would be beneficial for nurses involved in the management of patients with diabetes and would help them to implement an individualized plan for their patients.
 
CNE Credits:
Each activity is accredited for 0.5 ANCC Contact Hour(s)
 
CNE Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
 
Awarded 0.5 contact hour(s) of continuing nursing education of RNs and APNs per activity.
 
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
 
DISCLOSURE OF CONFLICTS OF INTEREST
Dr. Lawrence Blonde receives grant/research support from Eli Lilly and Co, Novo Nordisk, and Sanofi. He receives honoraria as a speaker for Amylin Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb, Janssen Pharmaceuticals, Merck & Co., Novo Nordisk, and Sanofi. He receives honoraria as a consultant for AstraZeneca, Bristol-Myers Squibb, Eisai, GlaxoSmithKline, Janssen, Merck & Co., Novo Nordisk, Quest Diagnostics, and Sanofi.
 
MLG Course Reviewer
Katherine Galluzzi, DO, CMD, FACOFP dist.
Professor and Chairperson, Department of Geriatrics
Philadelphia College of Osteopathic Medicine
Attending Physician, Family Medicine
Tenet Roxborough Memorial Hospital
Philadelphia, Pennsylvania
 
UMA/CCM Nurse Reviewer
Margaret Governo, EdD, APRN BC
CCM Lead Nurse Planner
Ultimate Medical Academy
 
MLG Course Reviewer - - Dr. Katherine Galluzzi has no relevant financial relationships to disclose.
 
CCM/UMA Lead Nurse Planner - - Margaret Governo, EdD, APRN BC has disclosed no significant financial relationships.
 
The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
 
Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
Lauren Welch, Vice President of Outcomes and Accreditation for Med Learning Group has nothing to disclose.
Chris Drury, Medical and Scientific Services for Med Learning Group has nothing to disclose.
 
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
 
During the course of this lecture, Dr. Blonde may mention the use of medications for both FDA-approved and non-approved indications
 
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME/CNE credit for this enduring activity. To receive CME/CNE credit participants must:
  1. Read the CME/CNE information and faculty disclosures.
  2. Participate in the enduring activity.
  3. Submit the evaluation form to the Med Learning Group.
You will receive your certificate via email within 30 days.
 
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based.
 
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
 
For CME questions, please contact: Med Learning Group at info@medlearninggroup.com
 
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/
 
 
Sponsored by Med Learning Group
 
This activity was co-provided by Ultimate Medical Academy/CCM.
 
 
This activity is supported by an educational grant from Lilly USA, LLC and Takeda Pharmaceuticals International, Inc., US Region.
 
 
Participation Statement
This educational activity provides training necessary for licensed attendees to maintain state licensing requirements. The tuition for this educational activity is subsidized in part by unrestricted educational grants, including for those attendees who have successfully completed the state licensing requirements for their respective fields.  This subsidy is reflected in the registration fees for this activity.
 
 Copyright © 2014 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
 
COURSE VIEWING REQUIREMENTS
Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 5.0+ for Mac OSX 10.5 and above

For video playback, install the latest version of Flash or Quicktime.
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above